In cases involving prostate cancer cells, the ANXA2/ANXA2R axis and the GAS6-AXL interaction, which both induce dormancy of cancer cells in the bone microenvironment [277], may represent rational targets for the therapy of skeletal metastasis [278] (Figure 2). The gene discussed is ANXA2; the disease is prostate cancer.